Journal Browser

Journal Browser

Special Issue "Nanomedicine Advances in the Treatment of Chronic Inflammation"

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Nanoscience".

Deadline for manuscript submissions: 31 March 2024 | Viewed by 88

Special Issue Editors

3B’s Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Barco, Portugal
Interests: nanomedicine; inflammatory diseases; cancer; biomaterials; nanotechnology; materials engineering and chemistry; advanced therapies; tissue engineering; regenerative medicine
Special Issues, Collections and Topics in MDPI journals
I3B's-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Guimarães, Portugal
Interests: biodegradable biomaterials; polymer science; natural origin biomaterials; surface biofunctionalization of biomaterials; innovative therapies for chronic inflammation; nanostructured biomaterials and composites; bone and cartilage tissue engineering; adult stem cells; advanced therapies; regenerative medicine; animal models for testing of biomaterials
Special Issues, Collections and Topics in MDPI journals
1. 3B’s Research Group, I3Bs—Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, Barco, 4805-017 Guimarães, Portugal
2. ICVS/3B’s–PT Government Associate Laboratory, Braga, 4805-017 Guimarães, Portugal
Interests: tissue engineering; regenerative medicine; biomaterials; biomimetics; biodegradable materials; 3D in vitro models; cancer modelling
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Acute inflammation is an efficient and essential temporarily restricted response for the maintenance of human health. However, failure to resolve acute inflammation leads to serious pathological conditions that jointly represent the leading cause of death worldwide today. Indeed, numerous challenging and devastating diseases are mainly caused by chronic inflammation or include chronic inflammation as a pathophysiologically important component.

Despite remarkable improvements in recent decades in the treatment of inflammation-related diseases, three main drawbacks remain unresolved: (i) severe adverse effects that often create a very high risk/benefit ratio; (ii) the underexplored heterogeneity of disease mechanisms and among patients; and (iii) limited efficacy as patients present reduced life expectancy that may be worsened due to different comorbidities. Indeed, the presence of one inflammatory disorder increases the probability of developing other diseases. Thus, therapies that could safely and effectively treat chronic inflammation, overcoming these limitations, must urgently be developed.

This Special Issue aims to improve our knowledge about the latest achievements in chronic inflammation treatment. This Special Issue will publish original research articles regarding innovative, targeted, and/or precision nanomedicine strategies for chronic inflammation. Review articles with critical and detailed analysis of the published research and forecasting future avenues for research in this field are also valuable to this Special Issue.

Dr. Helena Ferreira
Dr. Nuno M. Neves
Prof. Dr. Rui L. Reis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers

This special issue is now open for submission.
Back to TopTop